The trajectory of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the healthcare landscape . While its groundbreaking success and generation of vast in earnings , the exclusivity end has opened the floodgates for alternative medications, significantly diminishing earnings potential . This shift ra